A scientific experiment to study the effects of the drug Ropivacaine with two additives, Clonidine and Dexmedetomidine, instilled inside abdomen in patients undergoing elective laparoscopic cholecystectomy

Not yet recruiting

• Conditions: Medical and Surgical,

• Registration Number: CTRI/2022/11/047103
• Lead Sponsor: Department of Anesthesiology

Brief Summary

This study is a prospective randomized double-blind control study comparing the analgesic efficacy of Ropivacaine with a2 agonist adjuvants for intraperitoneal instillation in patients undergoing laparoscopic cholecystectomy in KR Hospital

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-07-11
• Study Start: 2022-11-21

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 90

Inclusion Criteria

All ASA grade I and grade II patients between 19-60 years age group.

Exclusion Criteria

• ·All ASA grade III and IV patients.
• ·Diabetes and Hypertension.
• ·Cardiovascular, respiratory and neurological disorders.
• ·Obesity (BMI>30kg/m2).
• ·Drug allergy.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time for first request of analgesia	24 hours
Numerical Rating Score (NRS)	24 hours

Secondary Outcome Measures

Name	Time	Method
Adverse effects	24 hours
Patient satisfaction	48 hours

Trial Locations

Locations (1)

Surgery stone building, KR Hospital; 🇮🇳 Mysore, KARNATAKA, India

Surgery stone building, KR Hospital

🇮🇳Mysore, KARNATAKA, India

Priyadarshini Kalahasthi

Principal investigator

8825847078

kpriya91@gmail.com